https://www.selleckchem.com/products/ca3.html
The likelihood of developing recurrent dysplasia was higher among patients who did not achieve CE-IM (12%) compared to those who did achieve CE-IM (4%), p = 0.04. Similar findings were found in those who switched treatment modalities. EET is highly effective in eradication of Barrett's associated dysplasia and neoplasia.Both RFA and LNSC achieved similar rates of CE-D and CE-IM although LNSC required more sessions. Also, achievement of CE-IM was associated with less recurrence rates of dysplasia. EET is highly effective in eradication of Ba
Like
Comment
Share
